1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. SGLT2 Inhibitors

SGLT2 Inhibitors

46 - 60 of 78 Results
Sort Results:
Article: Expect to See More Admitted Patients Taking Empagliflozin or Liraglutide at Home August 2016
PL Voices: Cardiovascular Effects of Diabetes Medications August 2016
PL Voices: Renal Effects of Diabetes Medications August 2016
Article: Stop Saxagliptin or Alogliptin in Patients Who Develop Heart Failure June 2016
Commentary: DPP-4 Inhibitors (Gliptins) and Risk of Heart Failure June 2016
Other: Pharmacologic Management of Type 2 Diabetes: 2016 Interim Update June 2016
Article: Don't Stop Basal Insulins When Patients are NPO May 2016
Patient Education: Diabetes and Fasting May 2016
Patient Education: Have Diabetes? Take Care of Your Feet! April 2016
Article: Caution about ketoacidosis, UTIs, and other serious ADRs with the SGLT2s February 2016
Other: SGLT2 Inhibitors and Risk of Ketoacidosis and Serious UTIs February 2016
Article: Consider Canaglifozin As A Cause of Fractures December 2015
Commentary: Canagliflozin (Invokana, Invokamet) Bone Fracture Risk December 2015
Article: Don't be too Quick to Jump on the Jardiance (empagliflozin) Bandwagon November 2015
Chart: How to Switch Insulin Products November 2015